Literature DB >> 29523330

IgG subclasses' response to a set of mycobacterial antigens in different stages of Mycobacterium tuberculosis infection.

Leonardo Silva de Araujo1, Nidai de Bárbara Moreira da Silva2, Janaina Aparecida Medeiros Leung3, Fernanda Carvalho Queiroz Mello4, Maria Helena Féres Saad5.   

Abstract

Despite the reported high heterogeneity of the human immune response to tuberculosis (TB), new studies may contribute to the understanding of Mycobacterium tuberculosis immunopathogenesis. To investigate the patterns of humoral response during latent (LTBI) and active TB, we evaluated specific IgG subclasses' response, by ELISA, to a set of mycobacterial antigens (Rv2029c, Rv2031c, Rv2034, Rv2628, Rv3353c ESAT6:CFP10, and the new chimeric PstS1(285-374):CFP10) in plasma samples from exposed uninfected controls (ExC, n = 24), LTBI (n = 61), and TB (n = 15) donors. In general, the TB group showed statistically higher levels of IgG1, and lower levels of IgG3. Keeping specificities ≥90%, the highest sensitivity for TB detection was observed for IgG1-ESAT6:CFP10 (93.3%), followed by IgG2-Rv3353 (86.7%), IgG1-Rv3353 (69.2%) and IgG1-PstS1(285-374):CFP10 (53.3%). The combinatory of high IgG1-ESAT6:CFP10, followed by low IgG2-Rv3353c titers increased the specificity for TB detection to 100%. Only IgG3-ESAT6:CFP10 showed statistical differences between ExC and LTBI, detecting 50% of the LTBI donors. For the first time, higher levels of IgG2-PstS1(285-374):CFP10 and IgG2-Rv3353 were observed in LTBI and ExC, as compared with a lower or absent immunoreactivity among TB. This study demonstrates differential modulation of subclasses' profiles for the stages of infection, which may contribute to the further development of new diagnostic tools.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Humoral immunity; IgG; M. tuberculosis; Subclasses; Tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 29523330     DOI: 10.1016/j.tube.2017.10.010

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  5 in total

Review 1.  An Inflammatory Story: Antibodies in Tuberculosis Comorbidities.

Authors:  Milla R McLean; Lenette L Lu; Stephen J Kent; Amy W Chung
Journal:  Front Immunol       Date:  2019-12-09       Impact factor: 7.561

Review 2.  Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implications.

Authors:  Hemant Joshi; Divya Kandari; Rakesh Bhatnagar
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

3.  Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosis.

Authors:  Milla R McLean; Kathleen M Wragg; Ester Lopez; Sandra A Kiazyk; Terry Blake Ball; Joe Bueti; Stephen J Kent; Jennifer A Juno; Amy W Chung
Journal:  Clin Transl Immunology       Date:  2021-11-05

Review 4.  Diagnosis for Latent Tuberculosis Infection: New Alternatives.

Authors:  Claudia Carranza; Sigifredo Pedraza-Sanchez; Eleane de Oyarzabal-Mendez; Martha Torres
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

5.  Characteristic profile of antibody responses to PPD, ESAT-6, and CFP-10 of Mycobacterium tuberculosis in pulmonary tuberculosis suspected cases in Surabaya, Indonesia.

Authors:  Desak Nyoman Surya Suameitria Dewi; Ni Made Mertaniasih; Yuriko Ozeki; Wayan Tunas Artama; Mamiko Niki; Yoshitaka Tateishi; Manabu Ato; Sohkichi Matsumoto
Journal:  Braz J Infect Dis       Date:  2019-08-14       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.